Quantcast
Skip to main content
Environmental Health Perspectives Podcasts - The Researcher's Perspectives
Full
About EHP Publications Past Issues News By Topic Authors Subscribe Press International Inside EHP Email Alerts spacer
Environmental Health Perspectives (EHP) is a monthly journal of peer-reviewed research and news on the impact of the environment on human health. EHP is published by the National Institute of Environmental Health Sciences and its content is free online. Print issues are available by paid subscription.DISCLAIMER
spacer
NIEHS
NIH
DHHS
spacer
Current Issue

EHP Science Education Website




EHP on Twitter

AAAR

Comparative Toxicogenomics Database (CTD)

spacer
Environmental Health Perspectives Supplements Volume 108, Number S4, August 2000 Open Access
spacer
Interstitial Fibrosis and Growth Factors

Joseph A. Lasky1 and Arnold R. Brody2

1Section of Pulmonary Diseases, Critical Care and Environmental Medicine, Department of Medicine, and the Lung Biology Program, Tulane University Medical Center, New Orleans, Louisiana, USA; 2Departments of Pathology and Environmental Health Sciences, and the Lung Biology Program, Tulane University Medical Center, New Orleans, Louisiana, USA

Abstract

Interstitial pulmonary fibrosis (IPF) is scarring of the lung caused by a variety of inhaled agents including mineral particles, organic dusts, and oxidant gases. The disease afflicts millions of individuals worldwide, and there are no effective therapeutic approaches. A major reason for this lack of useful treatments is that few of the molecular mechanisms of disease have been defined sufficiently to design appropriate targets for therapy. Our laboratory has focused on the molecular mechanisms through which three selected peptide growth factors could play a role in the development of IPF. Hundreds of growth factors and cytokines could be involved in the complex disease process. We are studying platelet-derived growth factor because it is the most potent mesenchymal cell mitogen yet described, transforming growth factor beta because it is a powerful inducer of extracellular matrix (scar tissue) components by mesenchymal cells, and tumor necrosis factor alpha because it is a pleiotropic cytokine that we and others have shown is essentr the development of IPF in animal models. This review describes some of the evidence from studies in humans, in animal models, and in vitro, that supports the growth factor hypothesis. The use of modern molecular and transgenic technologies could elucidate those targets that will allow effective therapeutic approaches. Key words: , , , , , . -- Environ Health Perspect 108(suppl 4) :751-762 (2000) .

http://ehpnet1.niehs.nih.gov/docs/2000/suppl-4/751-762lasky/abstract.html


The full version of this article is available for free in HTML format.
spacer
 
Open Access Resources | Call for Papers | Career Opportunities | Buy EHP Publications | Advertising Information | Subscribe to the EHP News Feeds News Feeds | Inspector General USA.gov

Download Adobe Acrobat Reader to view PDF files located on this site.